Author name: Leonardo Arias

The robotics company reduced its 2026 cash burn forecast and said its development timeline remains on track, with a system design freeze expected by year-end.

Josh Ofman, company president, will step into the top job. Guggenheim Securities analysts said the leadership change “has been in development for some time and is unrelated to the NHS trial readout.”

The healthcare sector will increasingly adopt autonomous agents this year, but they’ll have to consider how to adapt their governance structures and manage cybersecurity risks as AI evolves, experts said at the HIMSS conference.

In an agreement between the two companies, GuardDog admitted it masqueraded as a healthcare provider in order to gain access to medical records.

The proposal would relax standards for facilities that use ethylene oxide, a cancer-causing gas, to sterilize medical devices.

With Ascendis Pharma entering the achondroplasia space last month and BridgeBio on deck, BioMarin faces competition. Adding to the pressure, the company suffered a setback Monday when it halted two studies of Voxzogo in other growth-related conditions following multiple cases of hip injuries in other trials of the drug.

  Como cualquier programador sabe, los «secretos» que se esconden en una página web pueden desvelarse al ver su código fuente HTML. Y para los jugadores, existe la oportunidad, en algunos casos, de encontrar pistas que puedan revelar la respuesta a los acertijos y p …

Health Secretary Robert F. Kennedy Jr. has become increasingly unpopular among several government officials, largely as a result of his antivaccine rhetoric and actions. Other contentious issues reportedly include the approval of an abortion pill and other controversial FDA decisions.

Structure Therapeutics’ oral obesity drug elicited a placebo-adjusted weight loss of 16.3% at 44 weeks in a Phase 2 trial. The biotech is planning to launch a late-stage program for the drug later this year.

Sana Biotechnology is looking to start clinical development for its type 1 diabetes therapy SC451 this year.